Longevity Medicine Miami Beach — Physician-Led | TrufaMED Skip to Content
Joint Commission Gold Seal of Approval FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE · ONE OF JUST 8 NATIONWIDE

For life-threatening emergencies, call 911

Longevity Medicine Miami Beach — Physician-Led | TrufaMED

Longevity Medicine Miami Beach — Physician-Led Healthspan Optimization at TrufaMED

Longevity is not a pill. It is a protocol — a sequenced, data-driven clinical program built around your specific biomarkers, cardiovascular architecture, metabolic function, and genetic risk profile. At TrufaMED, longevity medicine in Miami Beach is delivered by board-certified physicians inside a Joint Commission-accredited clinical setting. Not a wellness spa. Not a supplement counter. A physician-led practice with on-site diagnostics, IV therapy, hyperbaric oxygen therapy, and the infrastructure to execute a genuine precision longevity protocol.

Quick Answer

Longevity medicine at TrufaMED Miami Beach is a physician-led precision protocol encompassing comprehensive biomarker panels, cardiovascular and metabolic assessment, genetic screening, IV nutrient therapy (including NAD+), hyperbaric oxygen therapy, and quarterly physician reviews — all inside a Joint Commission-accredited clinical setting. Programs are structured through the SIGNATURE concierge tier. Individual biomarker panels, Galleri multi-cancer detection, and on-site IV and HBOT sessions are available a la carte.

What Is Longevity Medicine?

Longevity medicine is a clinical discipline focused on extending healthspan — the years of life spent in full physical, cognitive, and metabolic function — not merely lifespan. The distinction matters. Adding years to a life compromised by cardiovascular disease, cognitive decline, or chronic metabolic dysfunction is not the goal. The goal is compressing morbidity into the shortest possible window at the end of a long, high-function life.

Precision longevity medicine operates differently from standard annual physicals. Rather than checking boxes against population reference ranges, it constructs an individualized biological baseline — hormone levels, inflammatory markers, lipid sub-fractionation, glucose metabolism, body composition, cardiovascular risk architecture, genetic predispositions — and then designs an evidence-based intervention program specific to that individual’s risk profile and optimization opportunities.

The scientific foundation draws from research into the hallmarks of aging: genomic instability, telomere attrition, mitochondrial dysfunction, chronic low-grade inflammation (inflammaging), metabolic dysregulation, and cellular senescence. These are measurable biological processes with known clinical correlates, and many are modifiable with the right physician-supervised interventions.

A longevity medicine program at TrufaMED follows this precision framework — biomarker-driven, physician-supervised, and integrated across multiple therapeutic domains simultaneously.

The TrufaMED Longevity Protocol

The TrufaMED longevity protocol is not a menu of optional add-ons. It is a structured clinical program delivered in phases, anchored to measurable biomarker data, and reviewed by a physician at each stage.

Comprehensive Baseline Laboratory Panel

TrufaMED’s preventive care labs go significantly beyond a standard annual panel. The baseline covers the hormonal axis (testosterone, estradiol, DHEA-S, cortisol, SHBG, IGF-1), inflammation markers (high-sensitivity CRP, homocysteine, ferritin), glucose dysregulation (fasting glucose, fasting insulin, HbA1c, HOMA-IR), lipids and cardiovascular metabolic markers (comprehensive lipid panel, ApoB, Lp(a), lipoprotein particle number), kidney and liver function (complete metabolic panel, GFR, ALT, AST), thyroid (TSH, free T3, free T4, reverse T3, TPO antibodies), and micronutrient status (vitamin D, B12, magnesium, zinc, iron studies, omega-3 index).

These results are reviewed by the physician in a dedicated consultation, not auto-routed through a patient portal with a generic normal flag.

Cardiovascular Assessment

Cardiovascular disease remains the leading cause of premature death for the populations longevity medicine serves. TrufaMED’s cardiovascular assessment includes a resting 12-lead EKG performed and interpreted on-site, advanced lipoprotein sub-particle testing (ApoB and Lp(a) identify cardiovascular risk that standard LDL cholesterol misses), blood pressure architecture review, and physician-prescribed pharmacotherapy when indicated — statins, antihypertensives, aspirin — based on individualized 10-year ASCVD risk calculation.

Body Composition and Metabolic Assessment

Metabolic dysfunction — insulin resistance, visceral adiposity, sarcopenia — accelerates every other hallmark of aging. Body composition assessment gives the longevity protocol a measurable target and a baseline against which to track intervention outcomes. This includes skeletal muscle mass index, visceral fat estimation, and resting metabolic rate context.

Cognitive Baseline

TrufaMED establishes a cognitive baseline using validated screening tools in the physician consultation. This creates a longitudinal reference point — detectable cognitive change over 12 to 24 months that might otherwise go unnoticed until function is meaningfully compromised.

Galleri Multi-Cancer Early Detection

The Galleri multi-cancer detection test screens for more than 50 cancers from a single blood draw, many of which have no standard screening protocol. It detects cell-free DNA shed by early-stage tumors — cancers of the pancreas, ovary, kidney, liver, and others — before symptoms appear. At $1,150 self-pay, it is one of the highest-value preventive investments available to anyone over 40 with a family cancer history. TrufaMED performs the draw on-site and coordinates result interpretation.

Genetic Screening

TrufaMED integrates two forms of genetic screening into the longevity protocol. Empower hereditary cancer screening identifies inherited mutations (BRCA1/2, Lynch syndrome, and others) that significantly elevate lifetime cancer risk. Horizon genetic carrier screening identifies carrier status for inherited conditions that could affect offspring. Positive findings are never delivered without clinical context and a clear next-step plan.

Nutrition, Sleep, and Movement Assessment

Evidence-based longevity medicine assigns equal clinical weight to behavioral domains. The physician assessment covers protein adequacy (targeting 1.6–2.2g/kg body weight for muscle preservation), Mediterranean dietary pattern adherence, time-restricted eating when appropriate, sleep architecture (duration, fragmentation, circadian alignment), aerobic conditioning volume (targeting 150–300 minutes moderate-intensity weekly), and resistance training frequency (2–4 sessions weekly for skeletal muscle preservation). These are physician-reviewed clinical targets with measurable outcomes, not lifestyle suggestions.

IV Therapy Integration — NAD+, Glutathione, Vitamin C, Amino Acids

Intravenous nutrient therapy is integrated into the TrufaMED longevity protocol as a direct delivery mechanism for compounds that oral supplementation cannot reliably achieve at therapeutic concentrations. TrufaMED’s IV therapy program includes NAD+ IV therapy ($999 in-clinic) — a coenzyme central to mitochondrial energy production, DNA repair, and sirtuin activation, with levels declining approximately 50% between ages 40 and 60. Also included: glutathione IV (the body’s master antioxidant), high-dose Vitamin C, amino acid formulations supporting muscle protein synthesis, and Myers’ Cocktail ($280) for foundational micronutrient repletion. Every IV session includes complimentary red light therapy.

Hyperbaric Oxygen Therapy Integration

TrufaMED’s HBOT program is an integral component of the longevity protocol. Breathing 100% oxygen at 1.5–2.0 atmospheres pressure drives mitochondrial biogenesis, angiogenesis, anti-inflammatory signaling, and — per published human trial data (Hachmo et al., 2020) — telomere elongation and reduction in senescent cell burden. For comprehensive detail, see HBOT benefits explained.

Red Light Therapy

Red and near-infrared light at 630–850nm wavelengths activate cytochrome c oxidase in the mitochondrial electron transport chain, increasing ATP production. This photobiomodulation mechanism supports cellular energy and reduces localized inflammation. Included free with every in-clinic IV session at TrufaMED.

Physician Follow-Up and Quarterly Reviews

A longevity protocol without scheduled physician review is not a protocol — it is a one-time consultation. TrufaMED SIGNATURE concierge members receive quarterly physician reviews in which biomarker trends are assessed against the baseline, interventions are adjusted based on results, and the longitudinal plan is updated.

The Evidence Base — What Is Actually Supported

TrufaMED applies only interventions with credible evidence bases. The highest-confidence longevity interventions currently available include: strength training (the most powerful intervention against sarcopenia — the primary driver of functional decline after 60), aerobic conditioning (VO2 max is one of the strongest predictors of all-cause mortality across age groups), sleep optimization (7–9 hours per night), Mediterranean dietary pattern (consistently associated with reduced cardiovascular risk and preserved cognitive function), caloric restriction mimetics via time-restricted eating, NAD+ replenishment (direct clinical evidence for mitochondrial support), specific micronutrient repletion to optimal ranges, physician-prescribed statins and antihypertensives when cardiovascular risk criteria are met, metformin when clinically indicated (TAME trial data), and HBOT protocol (emerging peer-reviewed evidence for telomere elongation and senescent cell reduction).

What Makes TrufaMED’s Longevity Approach Different

Physician-Led, Not Coach-Led

The TrufaMED longevity program is designed and supervised by board-certified physicians — Dr. Uri Gedalia (board-certified general surgeon) and Dr. Shane D. Naidoo (board-certified emergency physician, medical director). Lab results are reviewed by a physician. Prescriptions are written by a physician. Protocol adjustments are made by a physician. This is a medical program. The distinction has direct implications for clinical safety, diagnostic accuracy, and the ability to prescribe pharmaceutical interventions when indicated.

Joint Commission Accredited Clinical Setting

TrufaMED is Florida’s only Joint Commission-accredited urgent care — one of approximately eight such accredited practices in the United States. Longevity medicine requires IV infusions, blood draws, EKGs, and sometimes pharmaceutical interventions. These should occur in an accredited clinical setting, not a wellness studio.

Fully Integrated On-Site Infrastructure

Most longevity programs refer patients to external facilities for labs, IV therapy, imaging, and HBOT. TrufaMED performs all of these under one roof: on-site laboratory, IV therapy suite (NAD+, glutathione, amino acids, Myers’ Cocktail), hyperbaric chamber (HBOT on-site), EKG, digital X-ray, and diagnostic ultrasound.

Your 90-Day Longevity Onboarding

Week 1 (Baseline): Comprehensive lab draw, EKG, body composition, cognitive screening, Galleri draw if indicated, genetic testing order, physician consultation (60–90 min), protocol design.

Weeks 2–6 (Intervention initiation): NAD+ IV series begins, HBOT protocol starts, dietary and movement targets set, micronutrient repletion initiated, pharmacotherapy prescriptions written where indicated.

Week 8 (Re-labs): Key biomarkers re-drawn — inflammatory markers, glucose/insulin, lipids, hormone levels, micronutrient status — to assess early response to interventions.

Week 12 (90-day review): Physician review of all data trends, protocol adjustment, quarterly goals set, Galleri and genetic results reviewed if outstanding, 12-month roadmap updated.

Cost and Access

  • Individual biomarker panels — available a la carte from the preventive care menu. A comprehensive metabolic and hormonal baseline typically runs $400–$800 self-pay. Insurance coverage varies — TrufaMED accepts most major carriers for eligible panels
  • Galleri multi-cancer detection — $1,150 self-pay
  • IV therapy sessions — NAD+ at $999 in-clinic, Myers’ Cocktail at $280, Superstar IV at $450. Full menu via IV therapy Miami
  • HBOT sessions — see pricing via HBOT Miami
  • SIGNATURE concierge membership — TrufaMED’s top-tier concierge program at $60,000+ annually includes comprehensive baseline labs, Galleri, genetic screening, quarterly physician reviews, unlimited visits, IV therapy sessions, and HBOT integration

Who Longevity Medicine Is For

  • Executives and high-performers — cognitive sharpness, physical stamina, and resilience to stress are professional assets
  • Anyone 40+ with cardiovascular or metabolic risk factors — family history of heart disease, hypertension, insulin resistance, or obesity
  • Patients with family histories of early cancer — Galleri and hereditary cancer genetic screening are most valuable here
  • Athletes extending their competitive prime — NAD+ replenishment, HBOT recovery protocols. See our HBOT recovery for athletes program
  • Patients managing chronic metabolic conditions — insulin resistance, thyroid dysfunction, adrenal dysregulation
  • Concierge patients seeking a deeper relationship — patients already in the TrufaMED ecosystem who want a formalized longitudinal longevity program

Frequently Asked Questions

Does insurance cover longevity medicine?

Partially. Standard diagnostic labs ordered within a physician encounter are typically covered by insurance when medically indicated. Advanced panels such as ApoB, Lp(a), and lipoprotein particle testing may require prior authorization or be billed self-pay. Galleri multi-cancer detection is $1,150 self-pay. HBOT and IV therapy are generally not covered for longevity indications. The SIGNATURE concierge membership fee may be partially reimbursable through HSA/FSA accounts.

How often should longevity labs be repeated?

The TrufaMED protocol includes re-labs at 8 weeks post-intervention-initiation, followed by comprehensive quarterly reviews. Key inflammatory and metabolic markers may be checked every 6–8 weeks during active optimization. Annual full-panel draws establish the long-term longitudinal baseline.

Do I need to stop any current medications before the program?

No. Do not stop any prescribed medications without physician instruction. The physician will review all current medications at baseline consultation and factor them into the biomarker interpretation and protocol design.

What dietary guidance does the program include?

The physician-reviewed framework targets adequate protein intake (1.6–2.2g per kilogram of body weight daily), a Mediterranean dietary pattern as the evidence-based foundation, and time-restricted eating in a 14:10 or 16:8 window where appropriate to activate autophagy pathways.

What results can I expect, and on what timeline?

Inflammatory markers typically improve within 6–12 weeks. Metabolic markers shift over 3–6 months. Body composition changes require 3–6 months of consistent resistance training and protein optimization. Subjective energy, sleep quality, and cognitive improvements are commonly reported within the first 30–60 days of NAD+ IV therapy and HBOT.

Are supplements included in the program?

Oral supplement recommendations are given based on specific biomarker results, not a generic stack. The protocol includes physician-reviewed micronutrient repletion through IV therapy when deficiencies are confirmed by labs. TrufaMED does not sell supplements.

How is TrufaMED different from a health coach or functional medicine provider?

TrufaMED longevity medicine is delivered by board-certified physicians (MD). Physicians can order and interpret clinical diagnostics with diagnostic authority and prescribe pharmaceutical interventions — statins, antihypertensives, metformin, hormone therapy — that non-physician providers cannot. TrufaMED is Joint Commission accredited, meeting hospital-grade patient safety standards.

Is HBOT required as part of the longevity program?

HBOT is integrated into the SIGNATURE concierge longevity protocol as a recommended component given its evidence base for mitochondrial support and senolytic effects. It is not mandatory for every patient. See HBOT benefits explained for the full clinical rationale.

Can I do a single longevity consultation without committing to a full membership?

Yes. Individual services — comprehensive lab panels, Galleri draw, genetic screening, IV therapy sessions, and HBOT sessions — are all available without a concierge membership. A physician-reviewed baseline consultation can be booked as a standalone visit through TrufaMED’s preventive care program.

What is the Galleri test and who should have it?

The Galleri test screens for more than 50 cancer types from a single blood draw using cell-free DNA analysis. It is $1,150 self-pay. TrufaMED recommends it for adults over 50, adults over 40 with a family cancer history, and anyone who wants the most comprehensive cancer surveillance available.

Begin Your Longevity Assessment. Physician-led. Joint Commission accredited. On-site labs, IV therapy, and HBOT — all in one clinical setting in Miami Beach. Explore the concierge program or call (305) 537-6396 to schedule a consultation.

TrufaMED Urgent Care and Concierge Medicine is located at 9445 Harding Avenue, Surfside, FL 33154 — directly adjacent to Miami Beach. Open 8 AM to 10 PM daily. Board-certified physicians on shift every day. Learn about our team and the physicians who lead the longevity program.

Longevity Medicine Miami Beach — Physician-Led Healthspan Optimization at TrufaMED

Longevity is not a pill. It is a protocol — a sequenced, data-driven clinical program built around your specific biomarkers, cardiovascular architecture, metabolic function, and genetic risk profile. At TrufaMED, longevity medicine in Miami Beach is delivered by board-certified physicians inside a Joint Commission-accredited clinical setting. Not a wellness spa. Not a supplement counter. A physician-led practice with on-site diagnostics, IV therapy, hyperbaric oxygen therapy, and the infrastructure to execute a genuine precision longevity protocol.

Quick Answer

Longevity medicine at TrufaMED Miami Beach is a physician-led precision protocol encompassing comprehensive biomarker panels, cardiovascular and metabolic assessment, genetic screening, IV nutrient therapy (including NAD+), hyperbaric oxygen therapy, and quarterly physician reviews — all inside a Joint Commission-accredited clinical setting. Programs are structured through the SIGNATURE concierge tier. Individual biomarker panels, Galleri multi-cancer detection, and on-site IV and HBOT sessions are available a la carte.

What Is Longevity Medicine?

Longevity medicine is a clinical discipline focused on extending healthspan — the years of life spent in full physical, cognitive, and metabolic function — not merely lifespan. The distinction matters. Adding years to a life compromised by cardiovascular disease, cognitive decline, or chronic metabolic dysfunction is not the goal. The goal is compressing morbidity into the shortest possible window at the end of a long, high-function life.

Precision longevity medicine operates differently from standard annual physicals. Rather than checking boxes against population reference ranges, it constructs an individualized biological baseline — hormone levels, inflammatory markers, lipid sub-fractionation, glucose metabolism, body composition, cardiovascular risk architecture, genetic predispositions — and then designs an evidence-based intervention program specific to that individual’s risk profile and optimization opportunities.

The scientific foundation draws from research into the hallmarks of aging: genomic instability, telomere attrition, mitochondrial dysfunction, chronic low-grade inflammation (inflammaging), metabolic dysregulation, and cellular senescence. These are measurable biological processes with known clinical correlates, and many are modifiable with the right physician-supervised interventions.

A longevity medicine program at TrufaMED follows this precision framework — biomarker-driven, physician-supervised, and integrated across multiple therapeutic domains simultaneously.

The TrufaMED Longevity Protocol

The TrufaMED longevity protocol is not a menu of optional add-ons. It is a structured clinical program delivered in phases, anchored to measurable biomarker data, and reviewed by a physician at each stage.

Comprehensive Baseline Laboratory Panel

TrufaMED’s preventive care labs go significantly beyond a standard annual panel. The baseline covers the hormonal axis (testosterone, estradiol, DHEA-S, cortisol, SHBG, IGF-1), inflammation markers (high-sensitivity CRP, homocysteine, ferritin), glucose dysregulation (fasting glucose, fasting insulin, HbA1c, HOMA-IR), lipids and cardiovascular metabolic markers (comprehensive lipid panel, ApoB, Lp(a), lipoprotein particle number), kidney and liver function (complete metabolic panel, GFR, ALT, AST), thyroid (TSH, free T3, free T4, reverse T3, TPO antibodies), and micronutrient status (vitamin D, B12, magnesium, zinc, iron studies, omega-3 index).

These results are reviewed by the physician in a dedicated consultation, not auto-routed through a patient portal with a generic normal flag.

Cardiovascular Assessment

Cardiovascular disease remains the leading cause of premature death for the populations longevity medicine serves. TrufaMED’s cardiovascular assessment includes a resting 12-lead EKG performed and interpreted on-site, advanced lipoprotein sub-particle testing (ApoB and Lp(a) identify cardiovascular risk that standard LDL cholesterol misses), blood pressure architecture review, and physician-prescribed pharmacotherapy when indicated — statins, antihypertensives, aspirin — based on individualized 10-year ASCVD risk calculation.

Body Composition and Metabolic Assessment

Metabolic dysfunction — insulin resistance, visceral adiposity, sarcopenia — accelerates every other hallmark of aging. Body composition assessment gives the longevity protocol a measurable target and a baseline against which to track intervention outcomes. This includes skeletal muscle mass index, visceral fat estimation, and resting metabolic rate context.

Cognitive Baseline

TrufaMED establishes a cognitive baseline using validated screening tools in the physician consultation. This creates a longitudinal reference point — detectable cognitive change over 12 to 24 months that might otherwise go unnoticed until function is meaningfully compromised.

Galleri Multi-Cancer Early Detection

The Galleri multi-cancer detection test screens for more than 50 cancers from a single blood draw, many of which have no standard screening protocol. It detects cell-free DNA shed by early-stage tumors — cancers of the pancreas, ovary, kidney, liver, and others — before symptoms appear. At $1,150 self-pay, it is one of the highest-value preventive investments available to anyone over 40 with a family cancer history. TrufaMED performs the draw on-site and coordinates result interpretation.

Genetic Screening

TrufaMED integrates two forms of genetic screening into the longevity protocol. Empower hereditary cancer screening identifies inherited mutations (BRCA1/2, Lynch syndrome, and others) that significantly elevate lifetime cancer risk. Horizon genetic carrier screening identifies carrier status for inherited conditions that could affect offspring. Positive findings are never delivered without clinical context and a clear next-step plan.

Nutrition, Sleep, and Movement Assessment

Evidence-based longevity medicine assigns equal clinical weight to behavioral domains. The physician assessment covers protein adequacy (targeting 1.6–2.2g/kg body weight for muscle preservation), Mediterranean dietary pattern adherence, time-restricted eating when appropriate, sleep architecture (duration, fragmentation, circadian alignment), aerobic conditioning volume (targeting 150–300 minutes moderate-intensity weekly), and resistance training frequency (2–4 sessions weekly for skeletal muscle preservation). These are physician-reviewed clinical targets with measurable outcomes, not lifestyle suggestions.

IV Therapy Integration — NAD+, Glutathione, Vitamin C, Amino Acids

Intravenous nutrient therapy is integrated into the TrufaMED longevity protocol as a direct delivery mechanism for compounds that oral supplementation cannot reliably achieve at therapeutic concentrations. TrufaMED’s IV therapy program includes NAD+ IV therapy ($999 in-clinic) — a coenzyme central to mitochondrial energy production, DNA repair, and sirtuin activation, with levels declining approximately 50% between ages 40 and 60. Also included: glutathione IV (the body’s master antioxidant), high-dose Vitamin C, amino acid formulations supporting muscle protein synthesis, and Myers’ Cocktail ($280) for foundational micronutrient repletion. Every IV session includes complimentary red light therapy.

Hyperbaric Oxygen Therapy Integration

TrufaMED’s HBOT program is an integral component of the longevity protocol. Breathing 100% oxygen at 1.5–2.0 atmospheres pressure drives mitochondrial biogenesis, angiogenesis, anti-inflammatory signaling, and — per published human trial data (Hachmo et al., 2020) — telomere elongation and reduction in senescent cell burden. For comprehensive detail, see HBOT benefits explained.

Red Light Therapy

Red and near-infrared light at 630–850nm wavelengths activate cytochrome c oxidase in the mitochondrial electron transport chain, increasing ATP production. This photobiomodulation mechanism supports cellular energy and reduces localized inflammation. Included free with every in-clinic IV session at TrufaMED.

Physician Follow-Up and Quarterly Reviews

A longevity protocol without scheduled physician review is not a protocol — it is a one-time consultation. TrufaMED SIGNATURE concierge members receive quarterly physician reviews in which biomarker trends are assessed against the baseline, interventions are adjusted based on results, and the longitudinal plan is updated.

The Evidence Base — What Is Actually Supported

TrufaMED applies only interventions with credible evidence bases. The highest-confidence longevity interventions currently available include: strength training (the most powerful intervention against sarcopenia — the primary driver of functional decline after 60), aerobic conditioning (VO2 max is one of the strongest predictors of all-cause mortality across age groups), sleep optimization (7–9 hours per night), Mediterranean dietary pattern (consistently associated with reduced cardiovascular risk and preserved cognitive function), caloric restriction mimetics via time-restricted eating, NAD+ replenishment (direct clinical evidence for mitochondrial support), specific micronutrient repletion to optimal ranges, physician-prescribed statins and antihypertensives when cardiovascular risk criteria are met, metformin when clinically indicated (TAME trial data), and HBOT protocol (emerging peer-reviewed evidence for telomere elongation and senescent cell reduction).

What Makes TrufaMED’s Longevity Approach Different

Physician-Led, Not Coach-Led

The TrufaMED longevity program is designed and supervised by board-certified physicians — Dr. Uri Gedalia (board-certified general surgeon) and Dr. Shane D. Naidoo (board-certified emergency physician, medical director). Lab results are reviewed by a physician. Prescriptions are written by a physician. Protocol adjustments are made by a physician. This is a medical program. The distinction has direct implications for clinical safety, diagnostic accuracy, and the ability to prescribe pharmaceutical interventions when indicated.

Joint Commission Accredited Clinical Setting

TrufaMED is Florida’s only Joint Commission-accredited urgent care — one of approximately eight such accredited practices in the United States. Longevity medicine requires IV infusions, blood draws, EKGs, and sometimes pharmaceutical interventions. These should occur in an accredited clinical setting, not a wellness studio.

Fully Integrated On-Site Infrastructure

Most longevity programs refer patients to external facilities for labs, IV therapy, imaging, and HBOT. TrufaMED performs all of these under one roof: on-site laboratory, IV therapy suite (NAD+, glutathione, amino acids, Myers’ Cocktail), hyperbaric chamber (HBOT on-site), EKG, digital X-ray, and diagnostic ultrasound.

Your 90-Day Longevity Onboarding

Week 1 (Baseline): Comprehensive lab draw, EKG, body composition, cognitive screening, Galleri draw if indicated, genetic testing order, physician consultation (60–90 min), protocol design.

Weeks 2–6 (Intervention initiation): NAD+ IV series begins, HBOT protocol starts, dietary and movement targets set, micronutrient repletion initiated, pharmacotherapy prescriptions written where indicated.

Week 8 (Re-labs): Key biomarkers re-drawn — inflammatory markers, glucose/insulin, lipids, hormone levels, micronutrient status — to assess early response to interventions.

Week 12 (90-day review): Physician review of all data trends, protocol adjustment, quarterly goals set, Galleri and genetic results reviewed if outstanding, 12-month roadmap updated.

Cost and Access

  • Individual biomarker panels — available a la carte from the preventive care menu. A comprehensive metabolic and hormonal baseline typically runs $400–$800 self-pay. Insurance coverage varies — TrufaMED accepts most major carriers for eligible panels
  • Galleri multi-cancer detection — $1,150 self-pay
  • IV therapy sessions — NAD+ at $999 in-clinic, Myers’ Cocktail at $280, Superstar IV at $450. Full menu via IV therapy Miami
  • HBOT sessions — see pricing via HBOT Miami
  • SIGNATURE concierge membership — TrufaMED’s top-tier concierge program at $60,000+ annually includes comprehensive baseline labs, Galleri, genetic screening, quarterly physician reviews, unlimited visits, IV therapy sessions, and HBOT integration

Who Longevity Medicine Is For

  • Executives and high-performers — cognitive sharpness, physical stamina, and resilience to stress are professional assets
  • Anyone 40+ with cardiovascular or metabolic risk factors — family history of heart disease, hypertension, insulin resistance, or obesity
  • Patients with family histories of early cancer — Galleri and hereditary cancer genetic screening are most valuable here
  • Athletes extending their competitive prime — NAD+ replenishment, HBOT recovery protocols. See our HBOT recovery for athletes program
  • Patients managing chronic metabolic conditions — insulin resistance, thyroid dysfunction, adrenal dysregulation
  • Concierge patients seeking a deeper relationship — patients already in the TrufaMED ecosystem who want a formalized longitudinal longevity program

Frequently Asked Questions

Does insurance cover longevity medicine?

Partially. Standard diagnostic labs ordered within a physician encounter are typically covered by insurance when medically indicated. Advanced panels such as ApoB, Lp(a), and lipoprotein particle testing may require prior authorization or be billed self-pay. Galleri multi-cancer detection is $1,150 self-pay. HBOT and IV therapy are generally not covered for longevity indications. The SIGNATURE concierge membership fee may be partially reimbursable through HSA/FSA accounts.

How often should longevity labs be repeated?

The TrufaMED protocol includes re-labs at 8 weeks post-intervention-initiation, followed by comprehensive quarterly reviews. Key inflammatory and metabolic markers may be checked every 6–8 weeks during active optimization. Annual full-panel draws establish the long-term longitudinal baseline.

Do I need to stop any current medications before the program?

No. Do not stop any prescribed medications without physician instruction. The physician will review all current medications at baseline consultation and factor them into the biomarker interpretation and protocol design.

What dietary guidance does the program include?

The physician-reviewed framework targets adequate protein intake (1.6–2.2g per kilogram of body weight daily), a Mediterranean dietary pattern as the evidence-based foundation, and time-restricted eating in a 14:10 or 16:8 window where appropriate to activate autophagy pathways.

What results can I expect, and on what timeline?

Inflammatory markers typically improve within 6–12 weeks. Metabolic markers shift over 3–6 months. Body composition changes require 3–6 months of consistent resistance training and protein optimization. Subjective energy, sleep quality, and cognitive improvements are commonly reported within the first 30–60 days of NAD+ IV therapy and HBOT.

Are supplements included in the program?

Oral supplement recommendations are given based on specific biomarker results, not a generic stack. The protocol includes physician-reviewed micronutrient repletion through IV therapy when deficiencies are confirmed by labs. TrufaMED does not sell supplements.

How is TrufaMED different from a health coach or functional medicine provider?

TrufaMED longevity medicine is delivered by board-certified physicians (MD). Physicians can order and interpret clinical diagnostics with diagnostic authority and prescribe pharmaceutical interventions — statins, antihypertensives, metformin, hormone therapy — that non-physician providers cannot. TrufaMED is Joint Commission accredited, meeting hospital-grade patient safety standards.

Is HBOT required as part of the longevity program?

HBOT is integrated into the SIGNATURE concierge longevity protocol as a recommended component given its evidence base for mitochondrial support and senolytic effects. It is not mandatory for every patient. See HBOT benefits explained for the full clinical rationale.

Can I do a single longevity consultation without committing to a full membership?

Yes. Individual services — comprehensive lab panels, Galleri draw, genetic screening, IV therapy sessions, and HBOT sessions — are all available without a concierge membership. A physician-reviewed baseline consultation can be booked as a standalone visit through TrufaMED’s preventive care program.

What is the Galleri test and who should have it?

The Galleri test screens for more than 50 cancer types from a single blood draw using cell-free DNA analysis. It is $1,150 self-pay. TrufaMED recommends it for adults over 50, adults over 40 with a family cancer history, and anyone who wants the most comprehensive cancer surveillance available.

Begin Your Longevity Assessment. Physician-led. Joint Commission accredited. On-site labs, IV therapy, and HBOT — all in one clinical setting in Miami Beach. Explore the concierge program or call (305) 537-6396 to schedule a consultation.

TrufaMED Urgent Care and Concierge Medicine is located at 9445 Harding Avenue, Surfside, FL 33154 — directly adjacent to Miami Beach. Open 8 AM to 10 PM daily. Board-certified physicians on shift every day. Learn about our team and the physicians who lead the longevity program.

Longevity Medicine Miami Beach — Physician-Led Healthspan Optimization at TrufaMED

Longevity is not a pill. It is a protocol — a sequenced, data-driven clinical program built around your specific biomarkers, cardiovascular architecture, metabolic function, and genetic risk profile. At TrufaMED, longevity medicine in Miami Beach is delivered by board-certified physicians inside a Joint Commission-accredited clinical setting. Not a wellness spa. Not a supplement counter. A physician-led practice with on-site diagnostics, IV therapy, hyperbaric oxygen therapy, and the infrastructure to execute a genuine precision longevity protocol.

Quick Answer

Longevity medicine at TrufaMED Miami Beach is a physician-led precision protocol encompassing comprehensive biomarker panels, cardiovascular and metabolic assessment, genetic screening, IV nutrient therapy (including NAD+), hyperbaric oxygen therapy, and quarterly physician reviews — all inside a Joint Commission-accredited clinical setting. Programs are structured through the SIGNATURE concierge tier. Individual biomarker panels, Galleri multi-cancer detection, and on-site IV and HBOT sessions are available a la carte.

What Is Longevity Medicine?

Longevity medicine is a clinical discipline focused on extending healthspan — the years of life spent in full physical, cognitive, and metabolic function — not merely lifespan. The distinction matters. Adding years to a life compromised by cardiovascular disease, cognitive decline, or chronic metabolic dysfunction is not the goal. The goal is compressing morbidity into the shortest possible window at the end of a long, high-function life.

Precision longevity medicine operates differently from standard annual physicals. Rather than checking boxes against population reference ranges, it constructs an individualized biological baseline — hormone levels, inflammatory markers, lipid sub-fractionation, glucose metabolism, body composition, cardiovascular risk architecture, genetic predispositions — and then designs an evidence-based intervention program specific to that individual’s risk profile and optimization opportunities.

The scientific foundation draws from research into the hallmarks of aging: genomic instability, telomere attrition, mitochondrial dysfunction, chronic low-grade inflammation (inflammaging), metabolic dysregulation, and cellular senescence. These are measurable biological processes with known clinical correlates, and many are modifiable with the right physician-supervised interventions.

A longevity medicine program at TrufaMED follows this precision framework — biomarker-driven, physician-supervised, and integrated across multiple therapeutic domains simultaneously.

The TrufaMED Longevity Protocol

The TrufaMED longevity protocol is not a menu of optional add-ons. It is a structured clinical program delivered in phases, anchored to measurable biomarker data, and reviewed by a physician at each stage.

Comprehensive Baseline Laboratory Panel

TrufaMED’s preventive care labs go significantly beyond a standard annual panel. The baseline covers the hormonal axis (testosterone, estradiol, DHEA-S, cortisol, SHBG, IGF-1), inflammation markers (high-sensitivity CRP, homocysteine, ferritin), glucose dysregulation (fasting glucose, fasting insulin, HbA1c, HOMA-IR), lipids and cardiovascular metabolic markers (comprehensive lipid panel, ApoB, Lp(a), lipoprotein particle number), kidney and liver function (complete metabolic panel, GFR, ALT, AST), thyroid (TSH, free T3, free T4, reverse T3, TPO antibodies), and micronutrient status (vitamin D, B12, magnesium, zinc, iron studies, omega-3 index).

These results are reviewed by the physician in a dedicated consultation, not auto-routed through a patient portal with a generic normal flag.

Cardiovascular Assessment

Cardiovascular disease remains the leading cause of premature death for the populations longevity medicine serves. TrufaMED’s cardiovascular assessment includes a resting 12-lead EKG performed and interpreted on-site, advanced lipoprotein sub-particle testing (ApoB and Lp(a) identify cardiovascular risk that standard LDL cholesterol misses), blood pressure architecture review, and physician-prescribed pharmacotherapy when indicated — statins, antihypertensives, aspirin — based on individualized 10-year ASCVD risk calculation.

Body Composition and Metabolic Assessment

Metabolic dysfunction — insulin resistance, visceral adiposity, sarcopenia — accelerates every other hallmark of aging. Body composition assessment gives the longevity protocol a measurable target and a baseline against which to track intervention outcomes. This includes skeletal muscle mass index, visceral fat estimation, and resting metabolic rate context.

Cognitive Baseline

TrufaMED establishes a cognitive baseline using validated screening tools in the physician consultation. This creates a longitudinal reference point — detectable cognitive change over 12 to 24 months that might otherwise go unnoticed until function is meaningfully compromised.

Galleri Multi-Cancer Early Detection

The Galleri multi-cancer detection test screens for more than 50 cancers from a single blood draw, many of which have no standard screening protocol. It detects cell-free DNA shed by early-stage tumors — cancers of the pancreas, ovary, kidney, liver, and others — before symptoms appear. At $1,150 self-pay, it is one of the highest-value preventive investments available to anyone over 40 with a family cancer history. TrufaMED performs the draw on-site and coordinates result interpretation.

Genetic Screening

TrufaMED integrates two forms of genetic screening into the longevity protocol. Empower hereditary cancer screening identifies inherited mutations (BRCA1/2, Lynch syndrome, and others) that significantly elevate lifetime cancer risk. Horizon genetic carrier screening identifies carrier status for inherited conditions that could affect offspring. Positive findings are never delivered without clinical context and a clear next-step plan.

Nutrition, Sleep, and Movement Assessment

Evidence-based longevity medicine assigns equal clinical weight to behavioral domains. The physician assessment covers protein adequacy (targeting 1.6–2.2g/kg body weight for muscle preservation), Mediterranean dietary pattern adherence, time-restricted eating when appropriate, sleep architecture (duration, fragmentation, circadian alignment), aerobic conditioning volume (targeting 150–300 minutes moderate-intensity weekly), and resistance training frequency (2–4 sessions weekly for skeletal muscle preservation). These are physician-reviewed clinical targets with measurable outcomes, not lifestyle suggestions.

IV Therapy Integration — NAD+, Glutathione, Vitamin C, Amino Acids

Intravenous nutrient therapy is integrated into the TrufaMED longevity protocol as a direct delivery mechanism for compounds that oral supplementation cannot reliably achieve at therapeutic concentrations. TrufaMED’s IV therapy program includes NAD+ IV therapy ($999 in-clinic) — a coenzyme central to mitochondrial energy production, DNA repair, and sirtuin activation, with levels declining approximately 50% between ages 40 and 60. Also included: glutathione IV (the body’s master antioxidant), high-dose Vitamin C, amino acid formulations supporting muscle protein synthesis, and Myers’ Cocktail ($280) for foundational micronutrient repletion. Every IV session includes complimentary red light therapy.

Hyperbaric Oxygen Therapy Integration

TrufaMED’s HBOT program is an integral component of the longevity protocol. Breathing 100% oxygen at 1.5–2.0 atmospheres pressure drives mitochondrial biogenesis, angiogenesis, anti-inflammatory signaling, and — per published human trial data (Hachmo et al., 2020) — telomere elongation and reduction in senescent cell burden. For comprehensive detail, see HBOT benefits explained.

Red Light Therapy

Red and near-infrared light at 630–850nm wavelengths activate cytochrome c oxidase in the mitochondrial electron transport chain, increasing ATP production. This photobiomodulation mechanism supports cellular energy and reduces localized inflammation. Included free with every in-clinic IV session at TrufaMED.

Physician Follow-Up and Quarterly Reviews

A longevity protocol without scheduled physician review is not a protocol — it is a one-time consultation. TrufaMED SIGNATURE concierge members receive quarterly physician reviews in which biomarker trends are assessed against the baseline, interventions are adjusted based on results, and the longitudinal plan is updated.

The Evidence Base — What Is Actually Supported

TrufaMED applies only interventions with credible evidence bases. The highest-confidence longevity interventions currently available include: strength training (the most powerful intervention against sarcopenia — the primary driver of functional decline after 60), aerobic conditioning (VO2 max is one of the strongest predictors of all-cause mortality across age groups), sleep optimization (7–9 hours per night), Mediterranean dietary pattern (consistently associated with reduced cardiovascular risk and preserved cognitive function), caloric restriction mimetics via time-restricted eating, NAD+ replenishment (direct clinical evidence for mitochondrial support), specific micronutrient repletion to optimal ranges, physician-prescribed statins and antihypertensives when cardiovascular risk criteria are met, metformin when clinically indicated (TAME trial data), and HBOT protocol (emerging peer-reviewed evidence for telomere elongation and senescent cell reduction).

What Makes TrufaMED’s Longevity Approach Different

Physician-Led, Not Coach-Led

The TrufaMED longevity program is designed and supervised by board-certified physicians — Dr. Uri Gedalia (board-certified general surgeon) and Dr. Shane D. Naidoo (board-certified emergency physician, medical director). Lab results are reviewed by a physician. Prescriptions are written by a physician. Protocol adjustments are made by a physician. This is a medical program. The distinction has direct implications for clinical safety, diagnostic accuracy, and the ability to prescribe pharmaceutical interventions when indicated.

Joint Commission Accredited Clinical Setting

TrufaMED is Florida’s only Joint Commission-accredited urgent care — one of approximately eight such accredited practices in the United States. Longevity medicine requires IV infusions, blood draws, EKGs, and sometimes pharmaceutical interventions. These should occur in an accredited clinical setting, not a wellness studio.

Fully Integrated On-Site Infrastructure

Most longevity programs refer patients to external facilities for labs, IV therapy, imaging, and HBOT. TrufaMED performs all of these under one roof: on-site laboratory, IV therapy suite (NAD+, glutathione, amino acids, Myers’ Cocktail), hyperbaric chamber (HBOT on-site), EKG, digital X-ray, and diagnostic ultrasound.

Your 90-Day Longevity Onboarding

Week 1 (Baseline): Comprehensive lab draw, EKG, body composition, cognitive screening, Galleri draw if indicated, genetic testing order, physician consultation (60–90 min), protocol design.

Weeks 2–6 (Intervention initiation): NAD+ IV series begins, HBOT protocol starts, dietary and movement targets set, micronutrient repletion initiated, pharmacotherapy prescriptions written where indicated.

Week 8 (Re-labs): Key biomarkers re-drawn — inflammatory markers, glucose/insulin, lipids, hormone levels, micronutrient status — to assess early response to interventions.

Week 12 (90-day review): Physician review of all data trends, protocol adjustment, quarterly goals set, Galleri and genetic results reviewed if outstanding, 12-month roadmap updated.

Cost and Access

  • Individual biomarker panels — available a la carte from the preventive care menu. A comprehensive metabolic and hormonal baseline typically runs $400–$800 self-pay. Insurance coverage varies — TrufaMED accepts most major carriers for eligible panels
  • Galleri multi-cancer detection — $1,150 self-pay
  • IV therapy sessions — NAD+ at $999 in-clinic, Myers’ Cocktail at $280, Superstar IV at $450. Full menu via IV therapy Miami
  • HBOT sessions — see pricing via HBOT Miami
  • SIGNATURE concierge membership — TrufaMED’s top-tier concierge program at $60,000+ annually includes comprehensive baseline labs, Galleri, genetic screening, quarterly physician reviews, unlimited visits, IV therapy sessions, and HBOT integration

Who Longevity Medicine Is For

  • Executives and high-performers — cognitive sharpness, physical stamina, and resilience to stress are professional assets
  • Anyone 40+ with cardiovascular or metabolic risk factors — family history of heart disease, hypertension, insulin resistance, or obesity
  • Patients with family histories of early cancer — Galleri and hereditary cancer genetic screening are most valuable here
  • Athletes extending their competitive prime — NAD+ replenishment, HBOT recovery protocols. See our HBOT recovery for athletes program
  • Patients managing chronic metabolic conditions — insulin resistance, thyroid dysfunction, adrenal dysregulation
  • Concierge patients seeking a deeper relationship — patients already in the TrufaMED ecosystem who want a formalized longitudinal longevity program

Frequently Asked Questions

Does insurance cover longevity medicine?

Partially. Standard diagnostic labs ordered within a physician encounter are typically covered by insurance when medically indicated. Advanced panels such as ApoB, Lp(a), and lipoprotein particle testing may require prior authorization or be billed self-pay. Galleri multi-cancer detection is $1,150 self-pay. HBOT and IV therapy are generally not covered for longevity indications. The SIGNATURE concierge membership fee may be partially reimbursable through HSA/FSA accounts.

How often should longevity labs be repeated?

The TrufaMED protocol includes re-labs at 8 weeks post-intervention-initiation, followed by comprehensive quarterly reviews. Key inflammatory and metabolic markers may be checked every 6–8 weeks during active optimization. Annual full-panel draws establish the long-term longitudinal baseline.

Do I need to stop any current medications before the program?

No. Do not stop any prescribed medications without physician instruction. The physician will review all current medications at baseline consultation and factor them into the biomarker interpretation and protocol design.

What dietary guidance does the program include?

The physician-reviewed framework targets adequate protein intake (1.6–2.2g per kilogram of body weight daily), a Mediterranean dietary pattern as the evidence-based foundation, and time-restricted eating in a 14:10 or 16:8 window where appropriate to activate autophagy pathways.

What results can I expect, and on what timeline?

Inflammatory markers typically improve within 6–12 weeks. Metabolic markers shift over 3–6 months. Body composition changes require 3–6 months of consistent resistance training and protein optimization. Subjective energy, sleep quality, and cognitive improvements are commonly reported within the first 30–60 days of NAD+ IV therapy and HBOT.

Are supplements included in the program?

Oral supplement recommendations are given based on specific biomarker results, not a generic stack. The protocol includes physician-reviewed micronutrient repletion through IV therapy when deficiencies are confirmed by labs. TrufaMED does not sell supplements.

How is TrufaMED different from a health coach or functional medicine provider?

TrufaMED longevity medicine is delivered by board-certified physicians (MD). Physicians can order and interpret clinical diagnostics with diagnostic authority and prescribe pharmaceutical interventions — statins, antihypertensives, metformin, hormone therapy — that non-physician providers cannot. TrufaMED is Joint Commission accredited, meeting hospital-grade patient safety standards.

Is HBOT required as part of the longevity program?

HBOT is integrated into the SIGNATURE concierge longevity protocol as a recommended component given its evidence base for mitochondrial support and senolytic effects. It is not mandatory for every patient. See HBOT benefits explained for the full clinical rationale.

Can I do a single longevity consultation without committing to a full membership?

Yes. Individual services — comprehensive lab panels, Galleri draw, genetic screening, IV therapy sessions, and HBOT sessions — are all available without a concierge membership. A physician-reviewed baseline consultation can be booked as a standalone visit through TrufaMED’s preventive care program.

What is the Galleri test and who should have it?

The Galleri test screens for more than 50 cancer types from a single blood draw using cell-free DNA analysis. It is $1,150 self-pay. TrufaMED recommends it for adults over 50, adults over 40 with a family cancer history, and anyone who wants the most comprehensive cancer surveillance available.

Begin Your Longevity Assessment. Physician-led. Joint Commission accredited. On-site labs, IV therapy, and HBOT — all in one clinical setting in Miami Beach. Explore the concierge program or call (305) 537-6396 to schedule a consultation.

TrufaMED Urgent Care and Concierge Medicine is located at 9445 Harding Avenue, Surfside, FL 33154 — directly adjacent to Miami Beach. Open 8 AM to 10 PM daily. Board-certified physicians on shift every day. Learn about our team and the physicians who lead the longevity program.